Focal small bowel perforation: An adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants

Journal of Perinatology

Volumn 21, Issue 3, 2001, Pages 156-160

  Gordon, Phillip V ^a   Young, Mary L ^b   Marshall, Diane D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG INDUCED DISEASE; HUMAN; INFANT; META ANALYSIS; PERINATAL DRUG EXPOSURE; RISK; SMALL INTESTINE PERFORATION; STATISTICAL ANALYSIS; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTESTINAL PERFORATION; INTESTINE, SMALL; MALE; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS;

EID: 0034872715     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200520     Document Type: Article

References (26)

1. Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates
2. Focal intestinal perforation in the extremely-low-birth-weight infant
3. Focal intestinal perforation in preterm infants is an emerging disease
4. Intestinal perforation associated with indomethacin treatment in premature infants
5. Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists
6. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for broncho-pulmonary dysplasia
7. Localized intestinal perforation after enteral administration of indomethacin in premature infants
8. The etiology of gastrointestinal perforations in the newborn
9. Absent intestinal musculature: Anatomic evidence of an embryonic origin of the lesion
10. Neonatal intestinal perforation caused by congenital defects of the intestinal musculature
11. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants
12. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial
13. Spontaneous focal gastrointestinal perforation in very low birth weight infants
14. Serious complications in a randomized trial of early stress dose dexamethasone (DEX) in extremely low birth weight (ELBW) infants
15. Early postnatal dexamethasone therapy for the prevention of chronic lung disease
16. Early dexamethasone-attempting to prevent chronic lung disease
17. Meta-analysis in clinical research
18. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis
19. Meta-analysis: An update Mt Sinai
20. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants
21. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
22. Indexes of contrast and quantitative significance for comparisons of two groups
23. Dexamethasone administration to newborn mice alters mucosal and muscular morphology in the ileum and modulates insulin-like growth factor (IGF) I localization
24. Acute indomethacin-induced injury in the rat; early morphologic and biochemical changes
25. Early dexamethasone therapy in preterm infants: A follow-up study
26. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age